RSS-Feed abonnieren

DOI: 10.1055/s-0042-1758668
Bilateral Breast Phyllodes Tumor in Androgen Insensitivity Syndrome

Abstract
Phyllodes is a rare tumor found exclusively in females. It can be classified into benign, intermediate, or malignant variety based on the aggressive nature of the disease. With adequate preoperative clinical assessment combined with histopathology and radiological investigations the adequate treatment strategy can be formulated to avoid future recurrences. Complete androgen insensitivity syndrome (CAIS) is associated with a genotypic male, which can be confirmed by karyotyping, with phenotypic female characteristics. The present case is the first case of bilateral breast phyllodes tumor in a patient with CAIS. Preoperative assessment was suggestive of bilateral phyllodes tumor with bilateral gonads in the inguinal region which was confirmed to be testis postoperatively on histopathological analysis. A brief case report with review of literature is presented.
Publikationsverlauf
Eingereicht: 12. Mai 2022
Angenommen: 14. Oktober 2022
Artikel online veröffentlicht:
03. Februar 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J. Androgen insensitivity syndrome. Lancet 2012; 380 (9851): 1419-1428
- 2 Hoefgen HR, Merritt DF. Invasive ductal carcinoma in a 46,XY partial androgen insensitivity syndrome patient on hormone therapy. J Pediatr Adolesc Gynecol 2015; 28 (04) e95-e97
- 3 Rayzah M. Phyllodes tumors of the breast: a literature review. Cureus 2020; 12 (09) e10288
- 4 Lee PA, Houk CP, Ahmed SF, Hughes IA. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. Pediatrics 2006; 118 (02) e488-e500
- 5 Oakes MB, Eyvazzadeh AD, Quint E, Smith YR. Complete androgen insensitivity syndrome–a review. J Pediatr Adolesc Gynecol 2008; 21 (06) 305-310
- 6 Tian W, Wang Y, Zhang H, Liu G, Ma X, Xue F. Androgen insensitivity syndrome with gynandroblastoma and vulvar leiomyoma: case report and literature review. J Low Genit Tract Dis 2013; 17 (03) 335-339
- 7 Rutgers JL, Scully RE. The androgen insensitivity syndrome, a clinicopathologic study of 43 cases. Int J Gynecol Pathol 1991; l0 (02) 126-144
- 8 Hannema SE, Scott IS, Rajpert-De Meyts E, Skakkebaek NE, Coleman N, Hughes IA. Testicular development in the complete androgen insensitivity syndrome. J Pathol 2006; 208 (04) 518-527
- 9 Treves N, Sunderland DA. Cystosarcoma phyllodes of the breast: a malignant and a benign tumor; a clinicopathological study of seventy-seven cases. Cancer 1951; 4 (06) 1286-1332
- 10 Onkendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome. Ann Surg Oncol 2014; 21 (10) 3304-3309
- 11 Jang JH, Choi MY, Lee SK. et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 2012; 19 (08) 2612-2617